ZBH Operating Cash Flow
Period ending:
Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.
ZBH operating cash flow history
Cash generated from core business operations. The available annual fiscal periods series contains 28 observations from Dec 31, 1998 to Dec 31, 2025.
| Period ending | Operating Cash Flow (USD) |
|---|---|
| 1,697,100,000 | |
| 1,499,400,000 | |
| 1,581,600,000 | |
| 1,284,700,000 | |
| 1,499,200,000 | |
| 1,204,500,000 | |
| 1,585,800,000 | |
| 1,747,400,000 | |
| 1,582,300,000 | |
| 1,632,200,000 | |
| 862,800,000 | |
| 1,052,800,000 | |
| 963,100,000 | |
| 1,151,900,000 | |
| 1,176,900,000 | |
| 1,193,500,000 | |
| 1,117,500,000 | |
| 1,038,100,000 | |
| 1,084,400,000 | |
| 1,040,700,000 | |
| 878,200,000 | |
| 862,200,000 | |
| 494,800,000 | |
| 220,200,000 | |
| 171,800,000 | |
| 232,400,000 | |
| 180,000,000 | |
| 199,000,000 |
Compare operating cash flow
Other companies in Healthcare. Each page shows its own reporting periods and currency.
- Lilly (Eli) (LLY) operating cash flow
- Johnson & Johnson (JNJ) operating cash flow
- AbbVie (ABBV) operating cash flow
- UnitedHealth Group (UNH) operating cash flow
- Merck & Co. (MRK) operating cash flow
- Thermo Fisher Scientific (TMO) operating cash flow
- Amgen (AMGN) operating cash flow
- Gilead Sciences (GILD) operating cash flow
All ZBH financial metrics · ZBH stock overview · How to interpret financial metrics